| Delaware | 001-38273 | 94-3290283 | ||||||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
|
42307 Osgood Road, Suite I
Fremont, California
|
94539 |
||||
| (Address of Principal Executive Offices) | (Zip Code) | ||||
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | ||||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Class A Common Stock, par value $0.0001 per share | ACMR | The Nasdaq Stock Market LLC | ||||||||||||
| Exhibit | Description | |||||||
|
104
|
Press Release of ACM Research, Inc. dated November 5, 2025
Cover Page Interactive Data File (embedded within the XBRL document)
|
|||||||

| Three Months Ended September 30, | |||||||||||||||||||||||
| GAAP | Non-GAAP(1) | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (dollars in thousands, except EPS) | |||||||||||||||||||||||
| Revenue | $ 269,160 |
$ 203,976 |
$ 269,160 |
$ 203,976 |
|||||||||||||||||||
| Gross margin | 42.0 % |
51.4 % |
42.1 % |
51.6 % |
|||||||||||||||||||
| Income from operations | $ 28,923 |
$ 44,184 |
$ 36,485 |
$ 56,065 |
|||||||||||||||||||
| Net income attributable to ACM Research, Inc. | $ 35,889 |
$ 30,904 |
$ 24,795 |
$ 42,372 |
|||||||||||||||||||
| Basic EPS | $ 0.56 |
$ 0.49 |
$ 0.39 |
$ 0.68 |
|||||||||||||||||||
| Diluted EPS | $ 0.52 |
$ 0.45 |
$ 0.36 |
$ 0.63 |
|||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||
| GAAP | Non-GAAP(1) | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (dollars in thousands, except EPS) | |||||||||||||||||||||||
| Revenue | $ 656,879 |
$ 558,647 |
$ 656,879 |
$ 558,647 |
|||||||||||||||||||
| Gross margin | 45.7 % |
50.3 % |
45.9 % |
50.6 % |
|||||||||||||||||||
| Income from operations | $ 86,394 |
$ 107,009 |
$ 113,543 |
$ 147,801 |
|||||||||||||||||||
| Net income attributable to ACM Research, Inc. | $ 86,029 |
$ 72,547 |
$ 92,874 |
$ 114,490 |
|||||||||||||||||||
| Basic EPS | $ 1.35 |
$ 1.17 |
$ 1.45 |
$ 1.85 |
|||||||||||||||||||
| Diluted EPS | $ 1.26 |
$ 1.07 |
$ 1.36 |
$ 1.70 |
|||||||||||||||||||
In the United States: |
The Blueshirt Group |
||||
Steven C. Pelayo, CFA |
|||||
(360) 808-5154 |
|||||
steven@blueshirtgroup.co |
|||||
In China: |
The Blueshirt Group Asia |
||||
Gary Dvorchak, CFA |
|||||
+86 (138) 1079-1480 |
|||||
gary@blueshirtgroup.co |
|||||
| September 30, 2025 | December 31, 2024 | ||||||||||
| (Unaudited) | |||||||||||
| (In thousands) | |||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ 1,058,909 |
$ 407,445 |
|||||||||
| Restricted cash | 8,430 |
3,865 |
|||||||||
| Short-term time deposits | 30,922 |
17,277 |
|||||||||
| Short-term investment | 39,976 |
19,373 |
|||||||||
| Accounts receivable, net | 476,996 |
387,045 |
|||||||||
| Other receivables | 50,450 |
41,859 |
|||||||||
| Inventories, net | 676,409 |
597,984 |
|||||||||
| Advances to related parties | 927 |
1,024 |
|||||||||
| Prepaid expenses and other current assets | 15,143 |
7,507 |
|||||||||
| Total current assets | 2,358,162 |
1,483,379 |
|||||||||
| Property, plant and equipment, net | 296,714 |
269,272 |
|||||||||
| Operating lease right-of-use assets, net | 18,026 |
14,038 |
|||||||||
| Intangible assets, net | 2,706 |
3,461 |
|||||||||
| Long-term time deposits | — |
13,275 |
|||||||||
| Deferred tax assets | 26,641 |
14,781 |
|||||||||
| Long-term investments | 63,556 |
37,063 |
|||||||||
| Other long-term assets | 4,838 |
20,452 |
|||||||||
| Total assets | $ 2,770,643 |
$ 1,855,721 |
|||||||||
| Liabilities and Equity | |||||||||||
| Current liabilities: | |||||||||||
| Short-term borrowings | $ 45,049 |
$ 32,814 |
|||||||||
| Current portion of long-term borrowings | 48,637 |
44,472 |
|||||||||
| Related parties accounts payable | 23,323 |
16,133 |
|||||||||
| Accounts payable | 180,884 |
139,294 |
|||||||||
| Advances from customers | 203,506 |
243,949 |
|||||||||
| Deferred revenue | 15,550 |
8,537 |
|||||||||
| Income taxes payable | — |
12,779 |
|||||||||
| FIN-48 payable | 21,768 |
19,466 |
|||||||||
| Other payables and accrued expenses | 135,032 |
121,657 |
|||||||||
| Current portion of operating lease liability | 4,120 |
2,132 |
|||||||||
| Total current liabilities | 677,869 |
641,233 |
|||||||||
| Long-term borrowings | 193,356 |
105,525 |
|||||||||
| Long-term operating lease liability | 5,882 |
3,840 |
|||||||||
| Other long-term liabilities | 8,322 |
9,217 |
|||||||||
| Total liabilities | 885,429 |
759,815 |
|||||||||
| Commitments and contingencies | |||||||||||
| Equity: | |||||||||||
| Stockholders’ equity: | |||||||||||
| Class A Common stock | 6 |
6 |
|||||||||
| Class B Common stock | 1 |
1 |
|||||||||
| Additional paid-in capital | 1,105,129 |
677,476 |
|||||||||
| Retained earnings | 346,029 |
260,000 |
|||||||||
| Statutory surplus reserve | 30,514 |
30,514 |
|||||||||
| Accumulated other comprehensive loss | (48,999) |
(63,372) |
|||||||||
| Total ACM Research, Inc. stockholders’ equity | 1,432,680 |
904,625 |
|||||||||
| Non-controlling interests | 452,534 |
191,281 |
|||||||||
| Total equity | 1,885,214 |
1,095,906 |
|||||||||
| Total liabilities and equity | $ 2,770,643 |
$ 1,855,721 |
|||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
| ( In thousands, except share and per share data) | |||||||||||||||||||||||
Revenue |
$ 269,160 |
$ 203,976 |
$ 656,879 |
$ 558,647 |
|||||||||||||||||||
Cost of revenue |
156,011 |
99,142 |
356,719 |
277,908 |
|||||||||||||||||||
Gross profit |
113,149 |
104,834 |
300,160 |
280,739 |
|||||||||||||||||||
Operating expenses: |
|||||||||||||||||||||||
Sales and marketing |
22,311 |
15,759 |
60,756 |
47,067 |
|||||||||||||||||||
Research and development |
39,651 |
27,837 |
100,971 |
77,723 |
|||||||||||||||||||
General and administrative |
22,264 |
17,054 |
52,039 |
48,940 |
|||||||||||||||||||
Total operating expenses |
84,226 |
60,650 |
213,766 |
173,730 |
|||||||||||||||||||
Income from operations |
28,923 |
44,184 |
86,394 |
107,009 |
|||||||||||||||||||
Interest income |
3,100 |
2,967 |
10,452 |
7,122 |
|||||||||||||||||||
Interest expense |
(1,851) |
(1,208) |
(5,166) |
(2,923) |
|||||||||||||||||||
Realized gain on short-term investments |
- |
171 |
54 |
444 |
|||||||||||||||||||
Unrealized gain (loss) on short-term investments |
18,656 |
413 |
20,304 |
(1,151) |
|||||||||||||||||||
Other expense, net |
(3,411) |
(5,164) |
(4,019) |
(727) |
|||||||||||||||||||
Income from equity method investments |
3,670 |
1,316 |
6,395 |
101 |
|||||||||||||||||||
Income before income taxes |
49,087 |
42,679 |
114,414 |
109,875 |
|||||||||||||||||||
Income tax expense |
(2,689) |
(4,007) |
(6,733) |
(17,712) |
|||||||||||||||||||
Net income |
46,398 |
38,672 |
107,681 |
92,163 |
|||||||||||||||||||
Less: Net income attributable to non-controlling interests |
10,509 |
7,768 |
21,652 |
19,616 |
|||||||||||||||||||
Net income attributable to ACM Research, Inc. |
$ 35,889 |
$ 30,904 |
$ 86,029 |
$ 72,547 |
|||||||||||||||||||
Comprehensive income (loss): |
|||||||||||||||||||||||
Net income |
$ 46,398 |
$ 38,672 |
$ 107,681 |
$ 92,163 |
|||||||||||||||||||
Foreign currency translation adjustment, net of tax of nil |
9,899 |
17,089 |
15,554 |
10,376 |
|||||||||||||||||||
| Unrealized gain on available-for-sale investments, net of tax | 2,391 |
- |
2,391 |
- |
|||||||||||||||||||
Comprehensive Income |
58,688 |
55,761 |
125,626 |
102,539 |
|||||||||||||||||||
Less: Comprehensive income attributable to non-controlling interests |
13,017 |
10,842 |
25,224 |
21,458 |
|||||||||||||||||||
Comprehensive income attributable to ACM Research, Inc. |
$ 45,671 |
$ 44,919 |
$ 100,402 |
$ 81,081 |
|||||||||||||||||||
Net income attributable to ACM Research, Inc. per common share: |
|||||||||||||||||||||||
| Basic | $ 0.56 |
$ 0.49 |
$ 1.35 |
$ 1.17 |
|||||||||||||||||||
| Diluted | $ 0.52 |
$ 0.45 |
$ 1.26 |
$ 1.07 |
|||||||||||||||||||
Weighted average common shares outstanding used in computing per share amounts: |
|||||||||||||||||||||||
| Basic | 64,381,296 | 62,500,903 | 63,876,709 | 62,017,257 | |||||||||||||||||||
| Diluted | 68,414,313 | 66,671,526 | 67,551,302 | 66,512,143 | |||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
| ($ in thousands) | |||||||||||||||||||||||
Single wafer cleaning, Tahoe and semi-critical cleaning equipment |
$ 181,570 |
$ 160,985 |
$ 466,100 |
$ 423,676 |
|||||||||||||||||||
ECP (front-end and packaging), furnace and other technologies |
59,853 |
34,600 |
135,499 |
99,362 |
|||||||||||||||||||
Advanced packaging (excluding ECP), services & spares |
27,737 |
8,391 |
55,280 |
35,609 |
|||||||||||||||||||
Total Revenue By Product Category |
$ 269,160 |
$ 203,976 |
$ 656,879 |
$ 558,647 |
|||||||||||||||||||
| Three Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
|
Actual
(GAAP)
|
SBC |
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC |
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
||||||||||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | $ 269,160 |
$ - |
$ - |
$ 269,160 |
$ 203,976 |
$ - |
$ - |
$ 203,976 |
|||||||||||||||||||||||||||||||||||||||
| Cost of revenue | (156,011) |
(253) |
- |
(155,758) |
(99,142) |
(447) |
- |
(98,695) |
|||||||||||||||||||||||||||||||||||||||
Gross profit |
113,149 |
(253) |
- |
113,402 |
104,834 |
(447) |
- |
105,281 |
|||||||||||||||||||||||||||||||||||||||
Gross margin |
42.0 % |
0.1 % |
- |
42.1 % |
51.4 % |
0.2 % |
- |
51.6 % |
|||||||||||||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing |
(22,311) |
(1,601) |
- |
(20,710) |
(15,759) |
(2,594) |
- |
(13,165) |
|||||||||||||||||||||||||||||||||||||||
Research and development |
(39,651) |
(1,915) |
- |
(37,736) |
(27,837) |
(3,373) |
- |
(24,464) |
|||||||||||||||||||||||||||||||||||||||
General and administrative |
(22,264) |
(3,793) |
- |
(18,471) |
(17,054) |
(5,467) |
- |
(11,587) |
|||||||||||||||||||||||||||||||||||||||
Total operating expenses |
(84,226) |
(7,309) |
- |
(76,917) |
(60,650) |
(11,434) |
- |
(49,216) |
|||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | 28,923 |
(7,562) |
- |
36,485 |
44,184 |
(11,881) |
- |
56,065 |
|||||||||||||||||||||||||||||||||||||||
Unrealized gain on short-term investments |
18,656 |
- |
18,656 |
- |
413 |
- |
413 |
- |
|||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc. |
$ 35,889 |
$ (7,562) |
$ 18,656 |
$ 24,795 |
$ 30,904 |
$ (11,881) |
$ 413 |
$ 42,372 |
|||||||||||||||||||||||||||||||||||||||
| Basic EPS | $ 0.56 |
$ 0.39 |
$ 0.49 |
$ 0.68 |
|||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS | $ 0.52 |
$ 0.36 |
$ 0.45 |
$ 0.63 |
|||||||||||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||||||||
|
Actual
(GAAP)
|
SBC |
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
Actual
(GAAP)
|
SBC |
Other non-
operating adjustments
|
Adjusted
(Non-GAAP)
|
||||||||||||||||||||||||||||||||||||||||
| (In thousands) | |||||||||||||||||||||||||||||||||||||||||||||||
| Revenue | $ 656,879 |
$ - |
$ - |
$ 656,879 |
$ 558,647 |
$ - |
$ - |
$ 558,647 |
|||||||||||||||||||||||||||||||||||||||
| Cost of revenue | (356,719) |
(1,138) |
- |
(355,581) |
(277,908) |
(2,020) |
- |
(275,888) |
|||||||||||||||||||||||||||||||||||||||
Gross profit |
300,160 |
(1,138) |
- |
301,298 |
280,739 |
(2,020) |
- |
282,759 |
|||||||||||||||||||||||||||||||||||||||
Gross margin |
45.7 % |
0.2 % |
- |
45.9 % |
50.3 % |
0.4 % |
- |
50.6 % |
|||||||||||||||||||||||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing |
(60,756) |
(5,854) |
- |
(54,902) |
(47,067) |
(8,645) |
- |
(38,422) |
|||||||||||||||||||||||||||||||||||||||
Research and development |
(100,971) |
(7,270) |
- |
(93,701) |
(77,723) |
(12,082) |
- |
(65,641) |
|||||||||||||||||||||||||||||||||||||||
General and administrative |
(52,039) |
(12,887) |
- |
(39,152) |
(48,940) |
(18,045) |
- |
(30,895) |
|||||||||||||||||||||||||||||||||||||||
Total operating expenses |
(213,766) |
(26,011) |
- |
(187,755) |
(173,730) |
(38,772) |
- |
(134,958) |
|||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | 86,394 |
(27,149) |
- |
113,543 |
107,009 |
(40,792) |
- |
147,801 |
|||||||||||||||||||||||||||||||||||||||
Unrealized gain (loss) on short-term investments |
20,304 |
- |
20,304 |
- |
(1,151) |
- |
(1,151) |
- |
|||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to ACM Research, Inc. |
$ 86,029 |
$ (27,149) |
$ 20,304 |
$ 92,874 |
$ 72,547 |
$ (40,792) |
$ (1,151) |
$ 114,490 |
|||||||||||||||||||||||||||||||||||||||
| Basic EPS | $ 1.35 |
$ 1.45 |
$ 1.17 |
$ 1.85 |
|||||||||||||||||||||||||||||||||||||||||||
| Diluted EPS | $ 1.26 |
$ 1.36 |
$ 1.07 |
$ 1.70 |
|||||||||||||||||||||||||||||||||||||||||||